drugset / Trial / NCT01752842

Summary

This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.

Timeline

Start
2013-03
Primary completion
2018-02-23
Completion
2018-02-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 160 mg